Amicus Therapeutics, Inc. (LON:0HF9)
London · Delayed Price · Currency is GBP · Price in USD 8.24
-0.19 (-2.24%)
At close: Oct 10, 2025
Amicus Therapeutics Employees
Amicus Therapeutics had 499 employees as of December 31, 2024. The number of employees decreased by 18 or -3.48% compared to the previous year.
Employees
499
Change (1Y)
-18
Growth (1Y)
-3.48%
Revenue / Employee
835.45K GBP
Profits / Employee
-55.72K GBP
Market Cap
1.92B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 499 | -18 | -3.48% |
| Dec 31, 2023 | 517 | 33 | 6.82% |
| Dec 31, 2022 | 484 | -12 | -2.42% |
| Dec 31, 2021 | 496 | 13 | 2.69% |
| Dec 31, 2020 | 483 | -101 | -17.29% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| ConvaTec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| HUTCHMED (China) | 1,811 |
| Genus | 3,500 |
Amicus Therapeutics News
- 24 days ago - Interesting FOLD Put And Call Options For November 21st - Nasdaq
- 25 days ago - Amicus Therapeutics (FOLD) Upgraded by Needham with Increasing Sales Potential - GuruFocus
- 25 days ago - Amicus upgraded to Buy at Needham banking on kidney disease therapy - Seeking Alpha
- 25 days ago - Amicus (FOLD) Sees Favorable Upgrade Following Regulatory Developments - GuruFocus
- 25 days ago - FOLD: Needham Upgrades Amicus Therapeutics to Buy with $14 Target | FOLD Stock News - GuruFocus
- 25 days ago - This CSX Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - Benzinga
- 4 weeks ago - Amicus Therapeutics, Inc. (FOLD) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) - Seeking Alpha
- 5 weeks ago - Amicus (FOLD) Reveals Positive 4-Year Results for Pompe Disease Treatment - GuruFocus